Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study".
Le Bobinnec
G
G
D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001552:Benzazepines / Q000008:administration & dosage*; D002316:Cardiotonic Agents / Q000009:adverse effects*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D032984:Ethics, Research; D005260:Female; D008297:Male; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000662:veterinary*; D011724:Pyridazines / Q000009:adverse effects*; D012107:Research Design / Q000592:standards
D000959:Antihypertensive Agents; D001552:Benzazepines; D002316:Cardiotonic Agents; D011724:Pyridazines; C041648:pimobendan; C044946:benazepril